MAPT and chronic kidney disease: Is chronic kidney disease (CKD) associated with changes in plasma concentrations of phosphorylated tau biomarkers (ie, p-tau217 and p-tau181) and corresponding percent phosphorylated tau to unphosphorylated tau ratios (pT217/T217 and pT181/T181)?